Breaking News Instant updates and real-time market news.

NLNK

NewLink Genetics

$4.20

-3.12 (-42.62%)

, INCY

Incyte

$64.02

-19.05 (-22.93%)

08:22
04/09/18
04/09
08:22
04/09/18
08:22

NewLink Genetics downgraded to Neutral at Baird

As reported previously, Baird analyst Michael Ulz downgraded NewLink Genetics (NLNK) to Neutral from Outperform. The analyst cited the disappointing results from Incyte's (INCY) Phase-3 ECHO-301 study in melanoma. Given the uncertainty surrounding the opportunity after NewLink said it will revisit the indoximod clinical program following Incyte's news, Ulz lowered his price target to $5 from $22 on NewLink Genetics shares.

NLNK

NewLink Genetics

$4.20

-3.12 (-42.62%)

INCY

Incyte

$64.02

-19.05 (-22.93%)

  • 23

    Apr

  • 08

    May

  • 12

    Jun

NLNK NewLink Genetics
$4.20

-3.12 (-42.62%)

04/09/18
RHCO
04/09/18
DOWNGRADE
Target $5
RHCO
Hold
NewLink Genetics downgraded to Hold at SunTrust on Incyte trial failure
As reported late last week, SunTrust analyst Peter Lawson downgraded NewLink Genetics (NLNK) to Hold from Buy and lowered his price target to $5 from $19. Lawson cites the announcement of negative results from the Phase 3 ECHO-301 of epacadostat + Keytruda in melanoma by Incyte (INCY), saying the data also implies a "significant negative read through for NewLink's IDO agent, indoximod". Lawson adds that the results have led him to remove melanoma from his NewLink model and also reduce the probability of success in pancreatic cancer, lowering the probability of adjusted peak sales from $415M to just $11M.
04/09/18
CANT
04/09/18
DOWNGRADE
Target $7
CANT
Neutral
Cantor downgrades NewLink with $7 target on added indoximod uncertainty
Cantor Fitzgerald analyst Mara Goldstein downgraded NewLink Genetics (NLNK) to Neutral from Overweight and cut her price target for the shares to $7 from $26. The analyst cites NewLink's decision to revisit the indoximod clinical program as the reason for the downgrade. Goldstein previously highlighted the differentiating factors between indoximod and Incyte's (INCY) epacadostat, but she now has reduced confidence given a "lack of decisive commentary" from NewLink management.
04/09/18
CANT
04/09/18
DOWNGRADE
CANT
Neutral
NewLink Genetics downgraded to Neutral from Overweight at Cantor Fitzgerald
04/09/18
JEFF
04/09/18
DOWNGRADE
Target $4
JEFF
Hold
NewLink Genetics downgraded to Hold with $4 target at Jefferies
Jefferies analyst Biren Amin late Friday downgraded NewLink Genetics (NLNK) to Hold from Buy and cut his price target for the shares to $4 from $17. The stock closed Friday down 43%, or $3.12, to $4.20. The analyst does not see a scenario in which the company's IDO inhibitor can avoid the same fate as Incyte and Merck's epacadostat plus Keytruda failed study.
INCY Incyte
$64.02

-19.05 (-22.93%)

04/09/18
FBCO
04/09/18
NO CHANGE
Target $78
FBCO
Outperform
Incyte price target lowered to $78 from $145 at Credit Suisse
Credit Suisse analyst Alethia Young lowered her price target for Incyte to $78 from $145 following news on ECHO-301 and as she removes epacadostat from valuation. The analyst reiterates an Outperform rating on the shares.
04/09/18
MSCO
04/09/18
NO CHANGE
Target $76
MSCO
Overweight
Incyte price target lowered to $76 from $142 at Morgan Stanley
Morgan Stanley analyst Thomas Smith lowered his price target on Incyte to $76 after removing epacadostat from his model following the announcement that the ECHO-301 trial failed to show benefit over PD-1 monotherapy in melanoma. However, Smith believes Incyte shares already reflected a significant amount of investor skepticism heading into the ECHO-301 data and he views the company as having one of the deepest pipelines in SMID-cap biotech, supported by the Jakafi base business in myelofibrosis, Iclusig royalties in Europe and royalties from baricitinib. Smith keeps an Overweight rating on Incyte shares.
04/09/18
HCWC
04/09/18
NO CHANGE
Target $125
HCWC
Buy
Nektar data 'more robust' than Incyte's, says H.C. Wainwright
The failure of Incyte (INCY) and Merck's (MRK) Phase 3 study negatively impacted trading in Nektar Therapeutics (NKTR) shares on Friday, H.C. Wainwright analyst Debjit Chattopadhyay tells investors in a research note titled "Collateral Damage Not Surprising; Expecting ASCO-18 to Validate the Master T Cell Regulator Hypothesis." At this year's American Society of Clinical Oncology meeting, the analyst expects Nektar and partner Bristol-Myers Squibb (BMY) to unveil data from at least 40 advanced melanoma patients "supported by in-depth biomarker characterization to comprehensively ascertain the rationale of combining NKTR-214 with Opdivo." The rationale for combining NKTR-214 with Opdivo is "more robust" than epacadostat plus Keytruda, the analyst contends. Further, he believes data generated by the NKTR-214 plus Opdivo combination is "unambiguous." Chattopadhyay reiterates a Buy rating on Nektar shares with a $125 price target.

TODAY'S FREE FLY STORIES

VIX

Volatility Index S&P 500 Options

16:20
04/20/18
04/20
16:20
04/20/18
16:20
Options
Closing CBOE SPX and VIX Index summary for April 20th »

The CBOE Volatility Index…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

PRK

Park National

$105.24

-0.49 (-0.46%)

16:17
04/20/18
04/20
16:17
04/20/18
16:17
Hot Stocks
Park National raises quarterly dividend to 96c per share from 94c »

Park National's…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

PRK

Park National

$105.24

-0.49 (-0.46%)

16:17
04/20/18
04/20
16:17
04/20/18
16:17
Earnings
Breaking Earnings news story on Park National »

Park National reports Q1…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

$NSD

NASDAQ Market Internals

16:17
04/20/18
04/20
16:17
04/20/18
16:17
Technical Analysis
NASDAQ market internals summary »

Volume was average for…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

TRMB

Trimble

$36.57

-0.16 (-0.44%)

16:16
04/20/18
04/20
16:16
04/20/18
16:16
Hot Stocks
Trimble acquires assets of FabSuite, terms not disclosed »

Trimble announced that it…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

$NYE

NYSE Market Internals

16:16
04/20/18
04/20
16:16
04/20/18
16:16
Technical Analysis
NYSE market internals summary »

Volume was average for…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

CE

Celanese

$111.69

0.56 (0.50%)

16:15
04/20/18
04/20
16:15
04/20/18
16:15
Hot Stocks
Celanese names Benita Casey chief accounting officer »

Celanese Corporation…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 01

    May

  • 30

    May

SSW

Seaspan

$7.75

0.725 (10.32%)

16:15
04/20/18
04/20
16:15
04/20/18
16:15
Hot Stocks
Seaspan COO/General Counsel Mark Chu steps down »

Seaspan Corporation…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 24

    Apr

HON

Honeywell

$150.52

2.165 (1.46%)

, GE

General Electric

$14.54

0.55 (3.93%)

16:15
04/20/18
04/20
16:15
04/20/18
16:15
General news
On The Fly: Top stock stories for Friday »

Stocks opened little…

HON

Honeywell

$150.52

2.165 (1.46%)

GE

General Electric

$14.54

0.55 (3.93%)

AAPL

Apple

$165.71

-7.08 (-4.10%)

WFC

Wells Fargo

$52.57

1.02 (1.98%)

AGN

Allergan

$158.48

-0.11 (-0.07%)

WAB

Wabtec

$87.54

3.8 (4.54%)

SHPG

Shire

$164.43

3.63 (2.26%)

TKPYY

Takeda Pharmaceutical

MAT

Mattel

$12.95

-0.49 (-3.65%)

TSM

TSMC

$38.96

-0.57 (-1.44%)

PF

Pinnacle Foods

$60.58

5.38 (9.75%)

LLNW

Limelight Networks

$4.99

0.89 (21.71%)

TRU

TransUnion

$66.84

6.33 (10.46%)

CHD

Church & Dwight

$45.90

-2.82 (-5.79%)

CLW

Clearwater Paper

$26.90

-13.55 (-33.50%)

SKX

Skechers

$30.70

-11.3903 (-27.06%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 20

    Apr

  • 20

    Apr

  • 20

    Apr

  • 24

    Apr

  • 24

    Apr

  • 24

    Apr

  • 25

    Apr

  • 26

    Apr

  • 27

    Apr

  • 30

    Apr

  • 01

    May

  • 03

    May

  • 03

    May

  • 03

    May

  • 08

    May

  • 15

    May

  • 23

    May

  • 30

    May

  • 12

    Jun

  • 25

    Jun

  • 21

    Dec

WASH

Washington Trust

$56.35

0.45 (0.81%)

16:08
04/20/18
04/20
16:08
04/20/18
16:08
Earnings
Washington Trust reports Q1 adjusted EPS 93c, consensus 87c »

Q1 Returns on average…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 24

    Apr

  • 14

    May

INVE

Identiv

$3.54

0.03 (0.85%)

16:05
04/20/18
04/20
16:05
04/20/18
16:05
Syndicate
Breaking Syndicate news story on Identiv »

Identiv files to sell…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 16

    May

AA

Alcoa

$59.78

-0.47 (-0.78%)

, AAL

American Airlines

$46.58

-0.3 (-0.64%)

16:02
04/20/18
04/20
16:02
04/20/18
16:02
Periodicals
Breaking Periodicals news story on Alcoa, American Airlines, Alaska Air, Boeing, Delta Air Lines, General Electric, Southwest, United Continental, JetBlue »

FAA to prepare emergency…

AA

Alcoa

$59.78

-0.47 (-0.78%)

AAL

American Airlines

$46.58

-0.3 (-0.64%)

ALK

Alaska Air

$65.41

-0.14 (-0.21%)

BA

Boeing

$337.30

-3.25 (-0.95%)

DAL

Delta Air Lines

$55.33

0.27 (0.49%)

GE

General Electric

$14.65

0.655 (4.68%)

LUV

Southwest

$54.64

-0.14 (-0.26%)

UAL

United Continental

$71.73

1.485 (2.11%)

JBLU

JetBlue

$19.83

0.17 (0.86%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 20

    Apr

  • 23

    Apr

  • 24

    Apr

  • 25

    Apr

  • 25

    Apr

  • 26

    Apr

  • 09

    May

  • 10

    May

  • 29

    May

  • 30

    May

  • 26

    Jun

  • 29

    Jun

PSX

Phillips 66

$110.85

0.23 (0.21%)

15:55
04/20/18
04/20
15:55
04/20/18
15:55
Options
Phillips 66 put volume heavy and directionally bearish »

Bearish flow noted in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 27

    Apr

  • 09

    May

ULTI

Ultimate Software

$244.01

-4.76 (-1.91%)

15:51
04/20/18
04/20
15:51
04/20/18
15:51
Hot Stocks
Ultimate Software announces SMS Equipment to use its reporting product »

Ultimate Software…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 01

    May

  • 12

    Jun

C

Citi

$69.85

-0.43 (-0.61%)

, USB

U.S. Bancorp

$50.24

-0.45 (-0.89%)

15:49
04/20/18
04/20
15:49
04/20/18
15:49
Periodicals
Big U.S. banks race to launch mortgage apps as home lending slows, Reuters says »

Large U.S. banks are…

C

Citi

$69.85

-0.43 (-0.61%)

USB

U.S. Bancorp

$50.24

-0.45 (-0.89%)

JPM

JPMorgan

$111.07

-0.66 (-0.59%)

BAC

Bank of America

$30.19

-0.015 (-0.05%)

GS

Goldman Sachs

$251.52

-2.67 (-1.05%)

WFC

Wells Fargo

$52.49

0.94 (1.82%)

MS

Morgan Stanley

$54.11

-0.58 (-1.06%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 20

    Apr

  • 24

    Apr

  • 24

    Apr

  • 25

    Apr

  • 26

    Apr

  • 02

    May

  • 15

    May

  • 16

    May

  • 23

    May

  • 30

    May

  • 06

    Jun

  • 13

    Jul

  • 12

    Oct

T

AT&T

$34.67

-0.15 (-0.43%)

, VZ

Verizon

$48.01

-0.43 (-0.89%)

15:46
04/20/18
04/20
15:46
04/20/18
15:46
Periodicals
U.S. investigating wireless collusion claim against AT&T, Verizon, NY Times says »

The U.S. Department of…

T

AT&T

$34.67

-0.15 (-0.43%)

VZ

Verizon

$48.01

-0.43 (-0.89%)

S

Sprint

$6.00

0.045 (0.76%)

TMUS

T-Mobile

$63.28

0.02 (0.03%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 24

    Apr

  • 25

    Apr

  • 09

    May

HPE

HP Enterprise

$17.23

-0.19 (-1.09%)

15:45
04/20/18
04/20
15:45
04/20/18
15:45
Options
Hewlett Packard Enterprise call volume above normal and directionally bullish »

Bullish option flow…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 30

    May

  • 11

    Jun

T

AT&T

$34.64

-0.18 (-0.52%)

, VZ

Verizon

$47.99

-0.45 (-0.93%)

15:42
04/20/18
04/20
15:42
04/20/18
15:42
Periodicals
Breaking Periodicals news story on AT&T, Verizon, Sprint, T-Mobile »

U.S. investigating…

T

AT&T

$34.64

-0.18 (-0.52%)

VZ

Verizon

$47.99

-0.45 (-0.93%)

S

Sprint

$6.00

0.045 (0.76%)

TMUS

T-Mobile

$63.27

0.01 (0.02%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 24

    Apr

  • 25

    Apr

  • 09

    May

ALXN

Alexion

$106.59

-5.15 (-4.61%)

15:36
04/20/18
04/20
15:36
04/20/18
15:36
Hot Stocks
Alexion says no licence of Soliris was requested or granted in Brazil »

Recent media reports have…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 26

    Apr

SYNT

Syntel

$28.04

0.19 (0.68%)

15:35
04/20/18
04/20
15:35
04/20/18
15:35
Recommendations
Syntel analyst commentary  »

Syntel's rest of…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 22

    May

  • 23

    May

TRUP

Trupanion

$27.51

-1.42 (-4.91%)

15:35
04/20/18
04/20
15:35
04/20/18
15:35
Periodicals
Trupanion cost saving sharing may violate state laws, Capitol Forum says »

Insurance experts and…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 01

    May

  • 10

    May

BURL

Burlington Stores

$132.82

-3.36 (-2.47%)

15:30
04/20/18
04/20
15:30
04/20/18
15:30
Options
Bullish option play in Burlington Stores as shares slump »

Bullish option play in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

VIA

Viacom

$35.35

-0.25 (-0.70%)

, FOXA

21st Century Fox

$36.69

-0.51 (-1.37%)

15:29
04/20/18
04/20
15:29
04/20/18
15:29
Hot Stocks
Box Office Battle: 'A Quiet Place' expected to creep back into top spot »

Expected to return to the…

VIA

Viacom

$35.35

-0.25 (-0.70%)

FOXA

21st Century Fox

$36.69

-0.51 (-1.37%)

LGF.B

Lionsgate

$23.89

-0.55 (-2.25%)

VIAB

Viacom

$30.77

0.02 (0.07%)

CMCSA

Comcast

$33.14

-0.35 (-1.05%)

CMCSK

Comcast

LGF.A

Lionsgate

$25.72

-0.48 (-1.83%)

TWX

Time Warner

$95.98

-0.59 (-0.61%)

DIS

Disney

$100.01

-0.87 (-0.86%)

SNE

Sony

$49.70

-0.03 (-0.06%)

FOX

21st Century Fox

$36.12

-0.55 (-1.50%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 24

    Apr

  • 25

    Apr

  • 25

    Apr

  • 25

    Apr

  • 08

    May

  • 09

    May

  • 09

    May

ALXN

Alexion

$106.37

-5.37 (-4.81%)

15:28
04/20/18
04/20
15:28
04/20/18
15:28
Recommendations
Alexion analyst commentary  »

Alexion shares…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 26

    Apr

ANF

Abercrombie & Fitch

$26.36

-1.08 (-3.94%)

15:25
04/20/18
04/20
15:25
04/20/18
15:25
Options
Abercrombie & Fitch call volume above normal and directionally bullish »

Bullish option flow…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Apr

  • 12

    Jun

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.